Carestream gets FDA Clearance for Mobile X-Ray
New, more maneuverable unit joins competitors in better designed, mobile x-ray.
Carestream now has U.S. Food and Drug Administration (FDA) clearance for its DRX-Revolution Mobile X-Ray System.
Carestream put the mobile x-ray front and center at RSNA 2011, but now can take orders in the US.
The unit touts a wireless detector that can be used in other Carestream unites in a hospital to improve efficiency.
It also hosts software meant to help a radiographer quickly and accurately align the top tube with a grid for better image quality.
The top column is collapsible and a dual-drive systems enables the unit to make tight turns without strain on staff. The DRX-Revolution also offers a long tube head reach, so radiographers can conduct X-ray exams in crowded spots.
It will compete with other entries in the mobile x-ray market, such as Siemens Mobilett Mira Mobile Digital X-Ray System.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Expanded FDA Approval Allows Use of Pluvicto Prior to Chemotherapy in Patients with mCRPC
March 28th 2025Recent research demonstrated a 59 percent reduced risk of progression or death with the radioligand therapy Pluvicto in comparison to a change of androgen receptor pathway inhibitor (ARPI) for patients with metastatic castration-resistant prostate cancer (mCRPC).
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which will be unveiled at the American College of Cardiology (ACC) conference.
